August 15, 2025

FDA Approves Non-Opioid Fibromyalgia Therapy

Tonmya reduces fibromyalgia pain versus placebo in phase 3 trials, offering a non-opioid option with a generally well-tolerated safety profile.

Conexiant

August 15, 2025

Autoimmune Diseases Tied to Different Digestive Cancer Risks

Researchers examined celiac disease, SLE, MS, and T1D in relation to cancers of the pancreas, stomach, esophagus, small intestine, colon, rectum, liver, and gallbladder.

Conexiant

August 14, 2025

Mount Sinai Team Models Brain Decision-Making in Psychiatric Disorders

Scientists from the Icahn School of Medicine at Mount Sinai, working in collaboration with a team from the University of Texas at El Paso, have developed a novel computational framework for understanding how a region of the brain known as the striatum is involved in the everyday decisions we make and, importantly, how it might factor into impaired decision-making by individuals with psychiatric disorders like post-traumatic stress disorder and substance use disorder.

Mount Sinai New York

August 13, 2025

Medical Oddities: Spud Alert, Method Matters Most

Science spans snacks, cells, sheep, and sips in this week’s research highlights.

Conexiant

August 13, 2025

Stem-cell therapy is a 'big leap' for Parkinson's treatment

UCI Health joins a landmark stem cell trial showing early promise in reducing tremors and rebuilding brain networks.

UCI Health

August 13, 2025

AI Device Approval for Dementia Lacks Diversity

Most FDA-authorized artificial intelligence devices for Alzheimer disease lack transparent demographic data.

Conexiant

August 13, 2025

Low B Vitamins, ApoE e4 May Raise Dementia Risk

Older adults with low B-vitamin status and elevated homocysteine may have increased odds of cognitive dysfunction, and carriers of the ApoE e4 genotype faced compounded risk.

Conexiant

August 12, 2025

Single Cell Analysis: A New Dimension of Discovery

As spatial omics moves into 3D, what does this shift reveal about the changing priorities in single-cell analysis?

The Analytical Scientist

August 12, 2025

Behavioral Therapy Matches Drug for Parkinson’s Bladder 

“This study builds on the emerging literature suggesting behavioral therapy may have utility as an initial therapy for the most common urinary symptoms affecting persons with PD."

Conexiant